Selva Therapeutics Announces $3 Million Series A Financing to Advance a Novel Broad Spectrum Antiviral for Infectious Diseases, Including COVID-19

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/32Gw443
via IFTTT